Clinical Trial Update: Safety, Tolerability and Efficacy of Adjunctive TBO-309 in Reperfusion for Stroke With Tandem Occlusion [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety, tolerability, and efficacy of adjunctive TBO-309 for reperfusion in ischemic stroke with tandem occlusion; the trial is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• TBO-309

Snippet

Sponsor: ThromBio Pty. Ltd. | Conditions: Ischemic Stroke, Tandem Occlusion | Phase 2 | Status: RECRUITING